Copyright
©The Author(s) 2024.
World J Gastrointest Surg. May 27, 2024; 16(5): 1320-1327
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1320
Published online May 27, 2024. doi: 10.4240/wjgs.v16.i5.1320
Table 2 Safety of obese patients undergoing gastrointestinal surgery, n (%)
| Adverse event | Con (n = 30) | Res (n = 30) | χ2 | P value |
| Nausea and vomiting | 2 (6.67) | 0 (0.00) | ||
| Bradycardia | 4 (13.33) | 2 (6.67) | ||
| Hypotension | 3 (10.00) | 1 (3.33) | ||
| Apnea | 2 (6.67) | 1 (3.33) | ||
| Total | 11 (36.67) | 4 (13.33) | 4.356 | 0.037 |
- Citation: Deng YF, Jiang XR, Feng ZG. Comparative observation of the effectiveness and safety of remimazolam besylate versus dexmedetomidine in gastrointestinal surgery in obese patients. World J Gastrointest Surg 2024; 16(5): 1320-1327
- URL: https://www.wjgnet.com/1948-9366/full/v16/i5/1320.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i5.1320